tiprankstipranks
Trending News
More News >
Protalix Biotherapeutics (PLX)
:PLX

Compare Protalix (PLX) vs. Competitors

Compare
936 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Protalix
$2.04
$164.06M
29.35
-5.99%
1 Buy
0 Hold
0 Sell
Moderate Buy
Coherus Biosciences
$1.60
$193.39M
-1.01
12.68%
3 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$4.11
$566.92M
-13.87
305.30%
2 Buy
0 Hold
0 Sell
Moderate Buy
Protara Therapeutics
$5.01
$258.67M
8.21%
6 Buy
0 Hold
0 Sell
Strong Buy
Forte Biosciences
$33.39
$418.27M
-7.51
111.33%
2 Buy
0 Hold
0 Sell
Moderate Buy
Innate Pharma
$1.74
$164.01M
-2.92
4.37%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PLX
Protalix
2.04
-0.29
-12.45%
CHRS
Coherus Biosciences
1.60
0.28
21.21%
SLS
SELLAS Life Sciences Group
3.98
2.83
246.09%
TARA
Protara Therapeutics
5.01
0.25
5.25%
FBRX
Forte Biosciences
33.39
18.69
127.14%
IPHA
Innate Pharma
1.74
-0.02
-1.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts